Our Vision

Artic has begun its activity in regenerative medicine since 2020. Artic is ready to have international multidisciplinary collaboration with universities, start-up companies and scientific societies, world-wide with the aim of introducing novel regenerative medicine products and becoming one of the top 10^th  in molecular medicine market by  the next 10 years.